B
Bin-Zhi Qian
Researcher at University of Edinburgh
Publications - 43
Citations - 11251
Bin-Zhi Qian is an academic researcher from University of Edinburgh. The author has contributed to research in topics: Metastasis & Cancer. The author has an hindex of 22, co-authored 35 publications receiving 8834 citations. Previous affiliations of Bin-Zhi Qian include Guangzhou Medical University & Albert Einstein College of Medicine.
Papers
More filters
Journal ArticleDOI
Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage-Derived VEGFA
Allison S. Harney,Esther N. Arwert,David Entenberg,Yarong Wang,Peng Guo,Bin-Zhi Qian,Maja H. Oktay,Jeffrey W. Pollard,Jeffrey W. Pollard,Joan G. Jones,John S. Condeelis +10 more
TL;DR: Show that VEGFA signaling from TIE2(hi) TMEM macrophages results in local, transient vascular permeability and tumor cell intravasation, providing evidence for the mechanism underlying the association of TMEM with distant metastatic recurrence, offering a rationale for therapies targeting TMEM.
Journal ArticleDOI
Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver.
Xiangru Xu,Jian Huang,Zhigang Xu,Bin-Zhi Qian,Zhi-Dong Zhu,Qing Yan,Ting Cai,Xin Zhang,Hua-Sheng Xiao,Jian Qu,Feng Liu,Qiu-Hua Huang,Zhihong Cheng,Li Nenggan,Jianjun Du,Wei Hu,Kuntang Shen,Gang Lu,Gang Fu,Ming Zhong,Shuhua Xu,Wenyi Gu,Wei Huang,Xin-Tai Zhao,Geng-Xi Hu,Jian-Ren Gu,Zhu Chen,Ze-Guang Han +27 more
TL;DR: In this paper, a comprehensive characterization of gene expression profiles of hepatitis B virus-positive HCC through the generation of a large set of 5′-read expressed sequence tag (EST) clusters (11,065 in total) from HCC and non-cancerous liver samples, which then were applied to a cDNA microarray system containing 12,393 genes/ESTs and to comparison with a public database.
Journal ArticleDOI
Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
Russell Hughes,Bin-Zhi Qian,Charlotte Rowan,Munitta Muthana,Ioanna Keklikoglou,Oakley C. Olson,Simon Tazzyman,Sarah Danson,Christina L. Addison,Mark Clemons,Ana M. Gonzalez-Angulo,Johanna A. Joyce,Michele De Palma,Jeffrey W. Pollard,Jeffrey W. Pollard,Claire E. Lewis +15 more
TL;DR: This work reports that an alternatively activated (M2) subpopulation of TAMs accumulate around blood vessels in tumors after chemotherapy, where they promote tumor revascularization and relapse, in part, via VEGF-A release and rationalizes a strategy to leverage chemotherapeutic efficacy by selectively targeting this perivascular, relapse-promoting M2-related TAM cell population.
Journal ArticleDOI
Mouse models of metastasis: progress and prospects.
TL;DR: The currently available mouse models of metastasis are described, focusing on the mechanistic and therapeutic insights that have been gained by their application, strengths and weaknesses of different models and key technological advances that are generating more refined models.
Journal ArticleDOI
Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
Yan Zhou,Dong Yang,Qingcheng Yang,Xiao-Bin Lv,Wentao Huang,Zhenhua Zhou,Yaling Wang,Zhichang Zhang,Ting Yuan,Xiaomin Ding,Li-Na Tang,Jianjun Zhang,Junyi Yin,Yujing Huang,Wenxi Yu,Yonggang Wang,Chenliang Zhou,Yang Su,Aina He,Yuanjue Sun,Zan Shen,Bin-Zhi Qian,Wei Meng,Jia Fei,Yang Yao,Xinghua Pan,Peizhan Chen,Haiyan Hu +27 more
TL;DR: TIGIT blockade enhances the cytotoxicity effects of the primary CD3+ T cells with high proportion of TIGIT+ cells against osteosarcoma, and provides potential therapeutic targets for osteosARcoma.